CSPHFCSTONE PHARMACEUTICALS

About CSTONE PHARMACEUTICALS (CSPHF)

CSTONE PHARMACEUTICALS (CSPHF) is a Biotechnology company headquartered in Shanghai, China whose shares trade over-the-counter on the Pink tier.

CStone Pharmaceuticals (HKEX:2616) is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, 5 late-stage candidates are at pivotal trials. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone's vision is to become globally recognized as a leading Chinese biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide.

CSPHF key facts

Ticker symbol

CSPHF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Shanghai, China

Country of incorporation

KY

Reporting standard

International Reporting: Hong Kong Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with C